Published :
Tables : 100
Figures : 50
Category : Healthcare
No. of Pages : 180
Report Code : HC-1181
Immunoprecipitation Market Introduction: Global Immunoprecipitation Market to value over USD 720 Million and register a CAGR of over 4% during the forecast period 2020 to 2027. The immunoprecipitation market is witnessing significant growth due to a rise in research activities undertaken in the medical and life sciences industry. The research is usually sponsored and receives federal support which is also regarded as a substantial factor adding to the market’s growth during the forecast period. In order to identify antigens associated with autoimmune diseases, the market plays a key role and thus is profoundly demanded. The factors for early diagnosis of antigens, accuracy and speed are driving market growth. Based on type, the market is segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation and RNA immunoprecipitation. Individual immunoprecipitation is projected to be the fastest-growing sector during the forecasted time frame and register a healthy CAGR. The wide application spectrum offered by individual immunoprecipitation is a principal factor aiding its growth and highly precise diagnosis capability also aid in the expansion of the immunoprecipitation market size. By product type, the market is segmented into kits, reagents and accessories. The kits segment is expected to grow at a healthy CAGR due to their employment in various processes. Heavy demand due to universal operability encourages the growth of this segment. Based on the region, The Asia Pacific is predicted to grow at the highest CAGR during the forecast period. Federal support and increasing investments by governments and industries, growing biotechnology research in these regions, and rising awareness about personalized therapeutics are expected to drive the growth of these markets during the forecast period. North America is predicted to garner major market share due to the presence of global players and developed medical practices. Prominent players are : Thermo Fisher Scientific, Abcam, Bio-Rad Laboratories, Merck KGaA, GenScript., and BioLegend and Cell Signaling Technology. Market Segmentation : By Type Individual Immunoprecipitation Co-Immunoprecipitation Chromatin Immunoprecipitation RNA Immunoprecipitation By Product Kits Reagents Antibodies Primary Antibodies Secondary Antibodies Beads Agarose Beads Magnetic Beads Buffers Accessories By End User Academic & Research Institutes Pharmaceutical & Biotechnology Companies Contract Research Organizations By Region North America Europe Asia Pacific Latin America Middle East & Africa Competitive Landscape Thermo Fisher Scientific opened its new bioprocess design centre in Shanghai to connect and collaborate with biologic developers to design optimal bioprocessing solutions Abcam entered into an agreement with Roche, a leading biotech company, under which Abcam obtained the exclusive rights to the product portfolio of Spring, which consists of 243 recombinant rabbit monoclonal antibodies and 500 additional antibody products Objectives of the Study: To provide with an exhaustive analysis on the global immunoprecipitation market by type, by product, by end-user, and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financial and core competencies
Global Immunoprecipitation Market to value over USD 720 Million and register a CAGR of over 4% during the forecast period 2020 to 2027.
The immunoprecipitation market is witnessing significant growth due to a rise in research activities undertaken in the medical and life sciences industry. The research is usually sponsored and receives federal support which is also regarded as a substantial factor adding to the market’s growth during the forecast period. In order to identify antigens associated with autoimmune diseases, the market plays a key role and thus is profoundly demanded. The factors for early diagnosis of antigens, accuracy and speed are driving market growth.
Based on type, the market is segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation and RNA immunoprecipitation. Individual immunoprecipitation is projected to be the fastest-growing sector during the forecasted time frame and register a healthy CAGR. The wide application spectrum offered by individual immunoprecipitation is a principal factor aiding its growth and highly precise diagnosis capability also aid in the expansion of the immunoprecipitation market size.
By product type, the market is segmented into kits, reagents and accessories. The kits segment is expected to grow at a healthy CAGR due to their employment in various processes. Heavy demand due to universal operability encourages the growth of this segment.
Based on the region, The Asia Pacific is predicted to grow at the highest CAGR during the forecast period. Federal support and increasing investments by governments and industries, growing biotechnology research in these regions, and rising awareness about personalized therapeutics are expected to drive the growth of these markets during the forecast period. North America is predicted to garner major market share due to the presence of global players and developed medical practices.
Prominent players are : Thermo Fisher Scientific, Abcam, Bio-Rad Laboratories, Merck KGaA, GenScript., and BioLegend and Cell Signaling Technology.
Market Segmentation :
By Type
By Product
By End User
By Region
Competitive Landscape
Objectives of the Study:
1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Markets Covered 1.3.2 Years Considered for the Study 1.4 Currency 1.5 Stakeholders 1.6 Limitations 2 Research Methodology 2.1 Research Approach 2.1.1 Secondary Research 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Research 2.1.2.1 Key Data From Primary Sources 2.1.2.2 Break Down of Primaries 2.1.2.3 Key Industry Insights 2.2 Market Size Estimation 2.3 Data Triangulation Approach 2.4 Assumptions for the Study 3 Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4 Premium Insights 4.1 Immunoprecipitation: Market Overview 4.2 Immunoprecipitation Market, By Product (2020–2027) 4.3 North America: Immunoprecipitation Market, By Type (2020) 5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Market Drivers 5.2.1.1 Increasing Number of Life Sciences Research Activities 5.2.1.2 Growing Need to Identify Antigens That are Associated With Autoimmune Diseases 5.2.2 Restraints 5.2.2.1 Presence of Alternative Technologies 5.2.3 Opportunities 5.2.3.1 Increasing Focus on Biomarker Discovery 5.2.4 Challenges 5.2.4.1 Quality Concerns Over Research Antibodies 6 By Type 6.1 Introduction 6.2 Individual Immunoprecipitation 6.2.1 Increasing Demand for Biologics is Driving the Growth of the Market 6.3 Co-Immunoprecipitation 6.3.1 Increasing Use of Co-Ip to Study Protein Complexes Forms A Key Market Driver 6.4 Chromatin Immunoprecipitation 6.4.1 Growing Adoption of High-Throughput Technologies Will Contribute to Adoption of Chip 6.5 Rna Immunoprecipitation 6.5.1 Availability of Government Funding Will Drive the Adoption of Rip Kits 7 By Product 7.1 Introduction 7.2 Kits 7.2.1 Kits Segment to Account for the Largest Share of the Immunoprecipitation Market During the Forecast Period 7.3 Reagents 7.3.1 Antibodies 7.3.1.1 Antibodies, By Type 7.3.1.1.1 Primary Antibodies 7.3.1.1.1.1 Primary Antibodies to Account for the Largest Share of the Immunoprecipitation Antibodies Market During the Forecast Period 7.3.1.1.2 Secondary Antibodies 7.3.1.1.2.1 Low Cost of Production - A Major Factor Driving the Growth of the Secondary Antibodies Market 7.3.2 Beads 7.3.2.1 Beads, By Type 7.3.2.2 Agarose Beads 7.3.2.2.1 High Binding Capacity and Lower Cost – Factors Supporting the Wide Use of Agarose Beads in Research Laboratories 7.3.2.3 Magnetic Beads 7.3.2.3.1 Magnetic Bead-Based Separation Helps Increase Throughput and Reduces Hands-On Time 7.3.2.4 Buffers 7.3.2.4.1 Buffer Solutions Play an Important Role in Maintaining Ph Balance in Ip Assays 7.4 Accessories 8 By End User 8.1 Introduction 8.2 Academic & Research Institutes 8.2.1 Academic & Research Institutes are the Largest End Users of Immunoprecipitation 8.3 Pharmaceutical & Biotechnology Companies 8.3.1 Increasing Demand for Protein-Based Drugs to Drive the Demand for Immunoprecipitation in This End-User Segment 8.4 Contract Research Organizations 8.4.1 Growth in Outsourcing of Protein Purification Activities - A Major Factor Driving the Demand for Immunoprecipitation Technologies in Contract Research Organizations 9 By Region 9.1 Introduction 9.2 North America 9.2.1 Us 9.2.1.1 Growing Research Will Drive Market Growth 9.2.2 Canada 9.2.2.1 Increasing Genomics and Proteomics Research to Drive the Adoption of Immunoprecipitation in the Coming Years 9.3 Europe 9.3.1 Growth of the Life Sciences Sector Will Support the Demand for Immunoprecipitation 9.4 Asia Pacific 9.4.1 Increasing Demand for Novel Antibody and Protein-Based Drugs Support Market Growth in the Asia Pacific 9.5 Rest of the World 10 Competitive Landscape 10.1 Overview 10.2 Vendor Benchmarking 10.3 Competitive Leadership Mapping 10.3.1 Visionary Leaders 10.3.2 Innovators 10.3.3 Dynamic Differentiators 10.3.4 Emerging Companies 10.4 Market Ranking Analysis, 2020 10.5 Competitive Situation and Trends 10.5.1 Expansions 10.5.2 Collaborations, Partnerships, and Agreements 10.5.3 Product Launches 10.5.4 Acquisitions 11 Company Profiles (Business Overview, Products Offered, Recent Developments, FutureWise Perspective)* 11.1 Thermo Fisher Scientific 11.2 Abcam 11.3 Genscript 11.4 Merck KGaA 11.5 Bio-Rad Laboratories 11.6 Biolegend 11.7 Takara Bio 11.8 Rockland Immunochemicals 11.9 Cell Signaling Technology 11.10 Geno Technology 12. Assumptions and Acronyms 13. Research Methodology 14. List of Sources of Information (Primary and Secondary)
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders
1.6 Limitations
2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Break Down of Primaries
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Assumptions for the Study
3 Executive Summary
3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4 Premium Insights
4.1 Immunoprecipitation: Market Overview
4.2 Immunoprecipitation Market, By Product (2020–2027)
4.3 North America: Immunoprecipitation Market, By Type (2020)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Number of Life Sciences Research Activities
5.2.1.2 Growing Need to Identify Antigens That are Associated With Autoimmune Diseases
5.2.2 Restraints
5.2.2.1 Presence of Alternative Technologies
5.2.3 Opportunities
5.2.3.1 Increasing Focus on Biomarker Discovery
5.2.4 Challenges
5.2.4.1 Quality Concerns Over Research Antibodies
6 By Type
6.1 Introduction
6.2 Individual Immunoprecipitation
6.2.1 Increasing Demand for Biologics is Driving the Growth of the Market
6.3 Co-Immunoprecipitation
6.3.1 Increasing Use of Co-Ip to Study Protein Complexes Forms A Key Market Driver
6.4 Chromatin Immunoprecipitation
6.4.1 Growing Adoption of High-Throughput Technologies Will Contribute to Adoption of Chip
6.5 Rna Immunoprecipitation
6.5.1 Availability of Government Funding Will Drive the Adoption of Rip Kits
7 By Product
7.1 Introduction
7.2 Kits
7.2.1 Kits Segment to Account for the Largest Share of the Immunoprecipitation Market During the Forecast Period
7.3 Reagents
7.3.1 Antibodies
7.3.1.1 Antibodies, By Type
7.3.1.1.1 Primary Antibodies
7.3.1.1.1.1 Primary Antibodies to Account for the Largest Share of the Immunoprecipitation Antibodies Market During the Forecast Period
7.3.1.1.2 Secondary Antibodies
7.3.1.1.2.1 Low Cost of Production - A Major Factor Driving the Growth of the Secondary Antibodies Market
7.3.2 Beads
7.3.2.1 Beads, By Type
7.3.2.2 Agarose Beads
7.3.2.2.1 High Binding Capacity and Lower Cost – Factors Supporting the Wide Use of Agarose Beads in Research Laboratories
7.3.2.3 Magnetic Beads
7.3.2.3.1 Magnetic Bead-Based Separation Helps Increase Throughput and Reduces Hands-On Time
7.3.2.4 Buffers
7.3.2.4.1 Buffer Solutions Play an Important Role in Maintaining Ph Balance in Ip Assays
7.4 Accessories
8 By End User
8.1 Introduction
8.2 Academic & Research Institutes
8.2.1 Academic & Research Institutes are the Largest End Users of Immunoprecipitation
8.3 Pharmaceutical & Biotechnology Companies
8.3.1 Increasing Demand for Protein-Based Drugs to Drive the Demand for Immunoprecipitation in This End-User Segment
8.4 Contract Research Organizations
8.4.1 Growth in Outsourcing of Protein Purification Activities - A Major Factor Driving the Demand for Immunoprecipitation Technologies in Contract Research Organizations
9 By Region
9.1 Introduction
9.2 North America
9.2.1 Us
9.2.1.1 Growing Research Will Drive Market Growth
9.2.2 Canada
9.2.2.1 Increasing Genomics and Proteomics Research to Drive the Adoption of Immunoprecipitation in the Coming Years
9.3 Europe
9.3.1 Growth of the Life Sciences Sector Will Support the Demand for Immunoprecipitation
9.4 Asia Pacific
9.4.1 Increasing Demand for Novel Antibody and Protein-Based Drugs Support Market Growth in the Asia Pacific
9.5 Rest of the World
10 Competitive Landscape
10.1 Overview
10.2 Vendor Benchmarking
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Market Ranking Analysis, 2020
10.5 Competitive Situation and Trends
10.5.1 Expansions
10.5.2 Collaborations, Partnerships, and Agreements
10.5.3 Product Launches
10.5.4 Acquisitions
11 Company Profiles
(Business Overview, Products Offered, Recent Developments, FutureWise Perspective)*
11.1 Thermo Fisher Scientific
11.2 Abcam
11.3 Genscript
11.4 Merck KGaA
11.5 Bio-Rad Laboratories
11.6 Biolegend
11.7 Takara Bio
11.8 Rockland Immunochemicals
11.9 Cell Signaling Technology
11.10 Geno Technology
12. Assumptions and Acronyms
13. Research Methodology
14. List of Sources of Information (Primary and Secondary)
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics